Professor Alice Pébay is a NHMRC Senior Principal Research Fellow at The University of Melbourne and Royal Melbourne Hospital. She is also a Member of the ARC College of Experts, a Director of Genetic Cures Australia, Adjunct Associate Professor of the University of Western Australia’s Centre for Ophthalmology and Visual Science, a Member of the Australasian Friedreich Ataxia Gene Therapy Clinical Trials Committee, an Affiliate of the Australian Institute of Company Directors, and a Scientific Advisory Board Member of the ASX listed company PYC Therapeutics. She has also worked as the Head of the Neuroregeneration Research Unit at the Centre for Eye Research Australia.
Alice’s research aims to use patient specific pluripotent stem cells to model neurodegenerative diseases of the eye and brain. She has a proven track record in generating iPSCs and differentiating them into various cell types for disease modelling including those affecting the central nervous system and the eye. Alice and her collaborators have pioneered the use of automation for human pluripotent stem cell research in Australia, enabling the streamlining generation and maintenance of iPSC-derived cells from hundreds of patients. Alice was awarded a National Health & Medical Research Council (NHMRC) Career development Fellowship in 2012, subsequently an Australian Research Council Future Fellowship in 2014 and is now a NHMRC Senior Research Fellow. Alice is the primary inventor of three granted international patents related to stem cell technology.
Showing 1 reaction